Kymera Therapeutics Ratios (2019-2025) | KYMR

Ratios Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin -1,248.95%-644.46%-329.08%-432.39%-55.81%-100.19%-70.54%-133.69%-141.16%-222.88%-384.27%-354.79%-470.30%-239.72%-479.41%-263.01%-1,217.22%-40.44%-562.85%-198.78%-1,929.54%220.94%-337.10%-737.76%-3,350.90%
EBIT Margin -1,248.53%-642.83%-328.09%-431.63%-55.62%-99.98%-70.41%-133.54%-140.82%-222.55%-383.84%-354.44%-469.92%-239.36%-478.83%-262.72%-1,216.35%-40.33%-562.18%-198.54%-1,927.93%220.77%-336.77%-736.82%-3,347.36%
EBITDA Margin -1,202.11%-627.77%-312.66%-431.20%-56.29%-98.94%-69.30%-133.08%-141.27%-225.30%-407.82%-356.30%-470.44%-210.06%-412.18%-238.58%-1,093.10%-26.04%-483.93%-165.24%-1,562.60%202.77%-290.29%-664.67%-2,928.84%
Operating Margin -1,248.53%-642.83%-328.09%-431.63%-55.62%-99.98%-70.41%-133.54%-140.82%-222.55%-383.84%-354.44%-469.92%-239.36%-478.83%-262.72%-1,216.35%-40.33%-562.18%-198.54%-1,927.93%220.77%-336.77%-736.82%-3,347.36%
Net Margin -1,202.11%-628.10%-582.91%-425.46%-54.95%-99.22%-69.91%-133.16%-141.16%-222.88%-384.27%-318.60%-450.24%-216.03%-432.37%-234.96%-1,118.17%-30.01%-472.02%-163.98%-1,670.33%193.43%-296.75%-667.60%-2,973.05%
FCF Margin -600.11%-392.42%-464.32%889.41%-168.20%-122.91%-168.14%-184.73%-254.36%-423.79%-344.97%-371.85%-247.28%-506.83%-278.71%-840.21%-7.48%-456.82%-185.67%-1,336.57%171.47%-360.26%-527.88%-987.37%
Efficiency
Assets Average 497.27M475.86M449.47M538.42M624.18M584.48M543.24M580.95M620.80M608.52M597.92M567.16M564.07M722.00M847.14M930.43M1,006.44M948.17M1,024.69M1,116.56M
Equity Average -68.81M-84.10M-100.55M93.70M289.29M279.57M266.68M370.62M471.39M444.18M413.34M455.42M501.52M476.08M448.72M415.48M395.25M553.09M698.06M788.93M864.27M810.93M878.86M958.87M
Invested Capital -63.22M-74.41M-93.80M-107.29M294.69M283.89M275.25M258.10M483.13M459.64M428.72M397.95M512.88M490.15M462.00M435.43M395.54M394.97M711.20M684.92M892.93M835.62M786.23M971.48M946.26M
Asset Utilization Ratio 0.070.100.140.130.120.110.100.080.080.080.090.080.140.110.100.090.000.020.000.00
Leverage & Solvency
Interest Coverage Ratio -0.00M-392.77-330.79-567.68-288.68-473.41-548.71-883.21-409.10-666.55-900.80-995.37-0.00M-654.75-824.11-903.81-0.00M-371.38-838.13-834.84-0.00M-0.00M-0.00M-782.94-944.09
Equity Ratio -0.640.580.580.590.590.750.760.760.760.800.810.750.750.720.690.820.830.860.850.860.860.86
Times Interest Earned -0.00M-392.77-330.79-567.68-288.68-473.41-548.71-883.21-409.10-666.55-900.80-995.37-0.00M-654.75-824.11-903.81-0.00M-371.38-838.13-834.84-0.00M-0.00M-0.00M-782.94-944.09
Valuation
Enterprise Value -5.34M-91.96M-121.25M-60.97M1,649.46M2,460.25M1,511.80M1,824.85M2,461.69M2,820.15M1,767.28M626.14M647.15M1,422.72M1,054.40M955.67M312.46M2,099.53M1,706.76M1,979.32M2,440.24M1,475.82M1,249.15M2,176.37M3,541.08M
Market Capitalization 1,943.30M2,756.45M1,845.33M2,183.96M2,998.08M3,262.57M2,188.09M1,018.45M1,129.06M1,829.89M1,451.28M1,323.25M670.29M2,474.41M2,227.30M2,489.27M2,990.21M1,964.56M1,958.15M2,841.82M4,046.76M
Return Ratios
Return on Sales -5.18%-1.97%-1.36%-0.98%-0.91%-1.13%-1.38%-1.95%-2.48%-3.41%-3.45%-3.64%-3.34%-3.95%-2.11%-2.24%-2.10%-2.29%-84.48%-18.67%-422.41%
Return on Capital Employed -0.12%-0.13%-0.17%-0.18%-0.19%-0.25%-0.31%-0.32%-0.29%-0.31%-0.32%-0.37%-0.35%-0.27%-0.24%-0.23%-0.28%-0.31%-0.33%-0.32%
Return on Assets -0.09%-0.10%-0.13%-0.15%-0.16%-0.21%-0.26%-0.27%-0.26%-0.28%-0.29%-0.33%-0.29%-0.25%-0.22%-0.22%-0.26%-0.29%-0.30%-0.30%
Return on Equity 0.49%-0.48%-0.16%-0.17%-0.22%-0.21%-0.21%-0.28%-0.34%-0.34%-0.32%-0.36%-0.38%-0.45%-0.42%-0.32%-0.27%-0.25%-0.30%-0.34%-0.36%-0.35%